Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis

OBJECTIVE: The prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NAFLD/NASH) is increasing. NAFLD/NASH may progress to cirrhosis and hepatocellular carcinoma. However, most patients with NAFLD/NASH will die from a vascular cause. There are no approved pharmacological...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahjoubin-Tehran, Maryam, De Vincentis, Antonio, Mikhailidis, Dimitri P., Atkin, Stephen L., Mantzoros, Christos S., Jamialahmadi, Tannaz, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324680/
https://www.ncbi.nlm.nih.gov/pubmed/32673798
http://dx.doi.org/10.1016/j.molmet.2020.101049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324680/
https://www.ncbi.nlm.nih.gov/pubmed/32673798
http://dx.doi.org/10.1016/j.molmet.2020.101049

Ejemplares similares